Prospective study to evluate the efficacy and safety of the etanercept biosimilar SB4 in the treatment of autoimmune rheumatic disorders
Latest Information Update: 26 Jun 2019
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 26 Jun 2019 New trial record